Virtu Financial LLC Purchases Shares of 17,860 Zynex Inc. $ZYXI

Virtu Financial LLC purchased a new stake in shares of Zynex Inc. (NASDAQ:ZYXI) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 17,860 shares of the company’s stock, valued at approximately $39,000. Virtu Financial LLC owned about 0.06% of Zynex as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Tower Research Capital LLC TRC increased its holdings in shares of Zynex by 138.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 3,398 shares of the company’s stock valued at $27,000 after acquiring an additional 1,975 shares in the last quarter. Alhambra Investment Management LLC acquired a new position in shares of Zynex during the first quarter valued at about $30,000. XTX Topco Ltd acquired a new position in shares of Zynex during the fourth quarter valued at about $117,000. Dimensional Fund Advisors LP increased its holdings in shares of Zynex by 9.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 19,333 shares of the company’s stock valued at $155,000 after acquiring an additional 1,660 shares in the last quarter. Finally, Deutsche Bank AG increased its holdings in shares of Zynex by 172.8% during the first quarter. Deutsche Bank AG now owns 19,796 shares of the company’s stock valued at $44,000 after acquiring an additional 12,540 shares in the last quarter. 29.68% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ZYXI has been the topic of several recent analyst reports. Royal Bank Of Canada cut their price objective on shares of Zynex from $4.00 to $3.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 15th. HC Wainwright downgraded shares of Zynex from a “buy” rating to a “neutral” rating in a report on Friday, August 1st. Finally, LADENBURG THALM/SH SH upgraded shares of Zynex from a “neutral” rating to a “buy” rating and set a $3.70 price objective on the stock in a report on Friday, August 1st.

Zynex Price Performance

Shares of NASDAQ ZYXI opened at $1.52 on Tuesday. The business’s 50 day moving average price is $2.18 and its 200 day moving average price is $3.25. The firm has a market cap of $46.06 million, a P/E ratio of -1.62 and a beta of 0.91. Zynex Inc. has a 52 week low of $1.23 and a 52 week high of $9.42. The company has a quick ratio of 0.45, a current ratio of 0.62 and a debt-to-equity ratio of 0.56.

About Zynex

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.